DARU Journal of Pharmaceutical Sciences is an hybrid open-access peer-reviewed medical journal that was established in 1990 in Iran. It covers all aspects of the pharmaceutical sciences. The editor-in-chief is Mohammad Abdollahi. From 2018 the journal is published by Springer Science+Business Media on behalf of Tehran University of Medical Sciences.
The journal was established as a Persian language journal in 1990. English abstracts were included in 1995, and the language changed to English in 1999. In 2012, the journal moved to open access with BioMed Central, which lasted until 2017.
The journal is indexed and abstracted in:
According to the Journal Citation Reports, the journal has a 2024 impact factor of 2.1.
On November 2025 Retraction Watch reported that the journal published a paper co-authored by the editor-in-chief that contained fabricated references, repetitive language and other characteristics of AI generated text. Springer Nature flaged the paper on unespecific concerns.